Healthcare

Genu Recurvatum Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Genu Recurvatum Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Genu Recurvatum Market:

https://www.thebusinessresearchcompany.com/report/genu-recurvatum-global-market-report

According to The Business Research Company’s Genu Recurvatum Global Market Report 2024, The genu recurvatum market size has grown strongly in recent years. It will grow from $7.12 billion in 2023 to $7.57 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to orthopedic conditions prevalence, aging population, trauma and accidents, limited awareness and early diagnosis.

The genu recurvatum market size is expected to see strong growth in the next few years. It will grow to $9.71 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising awareness and education, advancements in treatment options, sports injury prevention and management, rehabilitation programs. Major trends in the forecast period include integration of digital health technologies, collaboration between orthopedic specialists and physical therapists, research on biomechanics and musculoskeletal health, focus on pediatric and adolescent cases, rehabilitation and strength training emphasis.

The increasing prevalence of orthopedic disorders is expected to propel the growth of the genu recurvatum market going forward. Orthopedic disorders refer to conditions that affect the musculoskeletal system, including the bones, joints, muscles, tendons, ligaments, and cartilage. Genu recurvatum causes knee pain and leads to knee osteoarthritis and other orthopedic disorders. The increasing cases of orthopedic conditions will demand treatment, which will support the market’s growth. For instance, in February 2022, according to the Office of Disease Prevention and Health Promotion, a US-based government health agency, it is anticipated that in 2040 78.4 million adults will have arthritis. Over 52.5 million adult Americans, or more than 22% of the population, have arthritis. Furthermore, in 2021, according to Versus Arthritis, a UK-based charity dedicated to people with arthritis, in 2022, there were 20,295,706 people with musculoskeletal conditions in the UK and for MSK disorders and joint problems. Therefore, the increasing prevalence of orthopedic disorders is driving the growth of the genu recurvatum market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=12425&type=smp

The genu recurvatum market covered in this report is segmented –

1) By Type: External Rotatory Deformity (ERD), Internal Rotatory Deformity (IRD), Non-Rotatory Deformity (NRD)

2) By Diagnosis: Magnetic Resonance Imaging (MRI), X-Rays, Other Diagnosis

3) By Treatment: Physical Therapy, Orthoses, Bracing, Surgery

4) By End-Users: Hospital, Clinics, Other End-Users

Technological advancements are a key trend gaining popularity in the genu recurvatum market. Major companies operating in the genu recurvatum market are developing technologically advanced products to sustain their position in the market. For instance, in November 2022, Ortho Development Corporation, a US-based orthopedic device design and manufacturing company, launched BKS Total PSI in collaboration with Materialize NV, a Belgium-based company in 3D printing / additive manufacturing. BKS Total PSI, driven by Materialize, improves total knee arthroplasty predictability and control by providing patient-specific virtual visualization, preoperative planning, and precise 3D-printed guidance.

The genu recurvatum market report table of contents includes: